|
Awards and recognition in the 2011-2012 period | ||
|
|
|
|
|
|
|
|
|
Name |
For what? |
When? |
|
Sustainability ratings in the capital market | ||
|
The Carbon Disclosure Project (CDP) is an independent not-for-profit organization that works on behalf of investors to motivate companies to transparently report their greenhouse gas emissions and water consumption. In the Carbon Disclosure Leadership Index, which assesses the extent and transparency of a company's reporting, Merck KGaA, Darmstadt, Germany scored 80 out of 100 possible points. In the Carbon Disclosure Performance Index, which rates a company's performance in reducing emissions, Merck KGaA, Darmstadt, Germany received a B rating on a scale of A to E, thus clearly placing it among the top-ranking companies from Germany, Austria and Switzerland. |
2012 | |
|
Since 2008, Merck KGaA, Darmstadt, Germany shares have been included in the FTSE4Good Index, the leading international sustainability index that annually evaluates companies’ ecological and ethical conduct. |
2011 and 2012 | |
|
The sustainability rating agency oekom research AG has given Merck KGaA, Darmstadt, Germany a C+ on a scale of A+ (top grade) to D-, which means Merck KGaA, Darmstadt, Germany has once more achieved prime status. This puts Merck KGaA, Darmstadt, Germany in tenth place in the pharmaceuticals & biotechnology sector. A total of 69 companies were evaluated. |
2011 | |
|
In a study comparing the sustainability performance of the 30 largest publicly traded German companies, Merck KGaA, Darmstadt, Germany holds 14th place (2009: 11th place). The analysis conducted by Sustainalytics followed the ESG method, which focuses on environmental, social and governance aspects. |
2011 | |
|
Since October 2011, Merck KGaA, Darmstadt, Germany shares have been included in the STOXX Global ESG Leaders sustainability index, which rates companies based on key environmental, social and governance criteria. |
2011 and 2012 | |
|
Awards for product reponsibility | ||
|
In the Access to Medicine Index, Merck KGaA, Darmstadt, Germany rose to eighth place (2011: 17th place). This index rates pharmaceutical companies with regard to their activities to improve access to medicines in developing health care systems. The index is published every two years by the Access to Medicine Foundation, an international not-for-profit organization. |
2012 | |
|
Our cross-divisional Innospire intiative received the Bio-IT World Best Practices Award for the “Knowledge Management” category. The award is granted by the Cambridge Healthtech Institute in the United States. |
2012 | |
|
Boston Business Journal Green Business Award |
The life science tools division’s Lab Water business field developed the ech2o-program for recycling water filter cartridges, which was recognized with the Boston Business Journal Green Business Award in May 2012. |
2012 |
|
Customer service for MS patients |
The MS LifeLines® initiative in the United States, sponsored by EMD Serono and Pfizer, was recognized by the J.D. Power and Associates Call Center Program for outstanding customer service to the MS community. |
2012 |
|
MassRecycle Business Innovation Award |
As one of the leading suppliers of products for the life science industry, our life science tools division and five customers jointly launched a take-back program for single-use products in the United States in 2012. The program was honored in November 2012 with the MassRecycle Business Innovation Award. |
2012 |
|
The Samplicity® filtration system from the life science tools division was chosen by R&D Magazine as one of the 100 most technologically significant products introduced into the marketplace in the United States. |
2012 | |
|
Awards for our performance as an employer | ||
|
Work and Family audit |
The charitable Hertie Foundation recognized the Merck KGaA, Darmstadt, Germany sites in Darmstadt and Gernsheim, Germany for the third consecutive time as being “family-friendly”. The distinction is based on an audit conducted on family-friendliness using predefined criteria and is valid for three years. |
2012 |
|
Top employer in the Netherlands |
The prescription medicines division was recognized by the Corporate Research Foundation as a top employer in the Netherlands. |
2011 |
|
The prescription medicines division was recognized by “The Globe and Mail” as one of the top employers in the Greater Toronto Area. |
2011 | |
|
Ranking of the best employers in Germany for senior scientists |
Merck KGaA, Darmstadt, Germany attained sixth place in the ranking of the best employers in Germany for senior scientists. |
2012 |
|
EMD Serono was recognized by “Training Magazine” as one of the companies in the United States that excel at employee development. |
2012 | |
|
Recognition of our social engagement | ||
|
Capital Philanthropy Award |
The prescription medicines division was presented the Capital Philanthropy Award in China for its Erbitux China Patients Aid Program. This award is among the most renowned ones given in Beijing for charitable activities. A total of 70 companies were recognized as a Philanthropic Enterprise Beijing. |
2012 |
|
Golden Bee CSR China Honor Roll |
In recognition of Merck KGaA, Darmstadt, Germany's exemplary corporate social engagement, Merck KGaA, Darmstadt, Germany was admitted to the Golden Bee CSR China Honor Roll. |
2012 |
|
Recognition as an “Empresa con Prácticas Transparentes (EPT)” in Mexico |
CETIFARMA , the Consejo de Etica y Transparencia de la Industria Farmacéutica en México (Council for ethics and transparency in the pharmaceutical industry), recognized Merck KGaA, Darmstadt, Germany in Mexico for its ethical and transparent conduct. |
2012 |
Further awards and recognition can be found in the printed version of our Annual Report 2011 (back page) and our Annual Report 2012 (p. 210).
back
